CORPORATE NEWS

12

2024-09

267
0
Guidelines for the Development of (Cellular) Immunotherapy Products Based on mRNA-LNP Technology

Hzymes offers comprehensive mRNA production solutions, including plasmid preparation, IVT process development, mRNA purification, LNP encapsulation, and related quality inspection platforms.

查看更多

10

2024-09

282
0
Streamlining Enzyme Quality Control with Fluorescence-Based RNase Assays: Best Practices for Production Teams

Hzymes has designed and developed RNase detection kit based on nucleic acid fluorescence substrate method.

查看更多

09

2024-09

223
0
Optimizing DNase Assay Kit Integration for High-Throughput Production

Hzymes has designed and developed DNase detection kit and RNase detection kit based on nucleic acid fluorescence substrate method.

查看更多

06

2024-09

398
0
How powerful is this series of HCD kits?

Host Cell DNA (HCD) detection is a critical step in ensuring the safety and quality of biological products like vaccines, recombinant proteins, antibody drugs, and cell therapies. Even with advanced purification methods, residual HCD can still pose immunogenicity and safety risks.

查看更多
MRNA vaccines and drug-related services
Recombinant Protein
Expression CRDMO Services
Biopharmaceutical raw materials and quality control reagent kits
Service subscription
Website & Brochure
© 2023 Hzymes Biotechnology Co., Ltd. All rights reserved
Powered by Feedback Manage